ENANTA PHARMACEUTICALS, INC Capital Expenditures Incurred but Not yet Paid
ENANTA PHARMACEUTICALS, INC (ENTA) reported Capital Expenditures Incurred but Not yet Paid of $6.00 thousand for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2026-08-12
- ENANTA PHARMACEUTICALS, INC capital expenditures incurred but not yet paid for the quarter ending 2026-06-30 was $6.00K, a 94.00% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC capital expenditures incurred but not yet paid for the quarter ending 2026-03-31 was $0.00.
- ENANTA PHARMACEUTICALS, INC capital expenditures incurred but not yet paid for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- ENANTA PHARMACEUTICALS, INC capital expenditures incurred but not yet paid for the quarter ending 2025-09-30 was -$1.40M.
- ENANTA PHARMACEUTICALS, INC capital expenditures incurred but not yet paid for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- ENANTA PHARMACEUTICALS, INC capital expenditures incurred but not yet paid for fiscal 2024 was $5.60M, a 1220.05% increase from fiscal 2023.
- ENANTA PHARMACEUTICALS, INC capital expenditures incurred but not yet paid for fiscal 2023 was $424.00K, a 65.10% decline from fiscal 2022.
- ENANTA PHARMACEUTICALS, INC capital expenditures incurred but not yet paid for fiscal 2022 was $1.22M, a 786.86% increase from fiscal 2021.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2026-06-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | $6.00K derived: sum of 2 quarters · filed 2026-08-12 | $6.00K 10-Q · filed 2026-08-12 | -$1.39M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $0.00 10-Q · filed 2026-05-13 | -$1.40M derived: sum of 3 quarters · filed 2026-05-13 | -$1.30M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 | -$1.40M derived: sum of 2 quarters · filed 2026-02-11 | -$1.30M derived: sum of 3 quarters · filed 2026-08-12 | -$2.43M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-09-30 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | -$1.30M derived: sum of 2 quarters · filed 2026-08-12 | -$2.43M derived: sum of 3 quarters · filed 2026-08-12 | $0.00 10-K · filed 2025-11-19 |
| 2025-06-30 | $100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-12 | -$1.03M derived: sum of 2 quarters · filed 2026-08-12 | $1.40M 10-Q · filed 2026-08-12 | $577.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $1.30M 10-Q · filed 2026-05-13 | $477.00K derived: sum of 3 quarters · filed 2026-05-13 | $4.10M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $2.43M 10-Q · filed 2026-02-11 | $1.61M derived: sum of 2 quarters · filed 2026-02-11 | $5.23M derived: sum of 3 quarters · filed 2026-02-11 | $7.54M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-09-30 | -$819.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | $2.81M derived: sum of 2 quarters · filed 2025-11-19 | $5.12M derived: sum of 3 quarters · filed 2025-11-19 | $5.60M 10-K · filed 2025-11-19 |
| 2024-06-30 | $3.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-13 | $5.94M derived: sum of 2 quarters · filed 2025-08-13 | $6.42M 10-Q · filed 2025-08-13 | $5.76M derived: sum of 4 quarters · filed 2025-11-19 |
| 2024-03-31 | $2.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-14 | $2.79M 10-Q · filed 2025-05-14 | $2.14M derived: sum of 3 quarters · filed 2025-11-19 | $1.60M derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-12-31 | $479.00K 10-Q · filed 2025-02-12 | -$172.00K derived: sum of 2 quarters · filed 2025-11-19 | -$708.00K derived: sum of 3 quarters · filed 2025-11-19 | -$176.00K derived: sum of 4 quarters · filed 2025-11-19 |
| 2023-09-30 | -$651.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-19 | -$1.19M derived: sum of 2 quarters · filed 2025-11-19 | -$655.00K derived: sum of 3 quarters · filed 2025-11-19 | $424.00K 10-K · filed 2025-11-19 |
| 2023-06-30 | -$536.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-07 | -$4.00K derived: sum of 2 quarters · filed 2024-08-07 | $1.07M 10-Q · filed 2024-08-07 | $1.88M derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | $532.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-08 | $1.61M 10-Q · filed 2024-05-08 | $2.41M derived: sum of 3 quarters · filed 2024-11-27 | $2.65M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-12-31 | $1.08M 10-Q · filed 2024-02-08 | $1.88M derived: sum of 2 quarters · filed 2024-11-27 | $2.12M derived: sum of 3 quarters · filed 2024-11-27 | $2.25M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-09-30 | $803.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $1.04M derived: sum of 2 quarters · filed 2024-11-27 | $1.17M derived: sum of 3 quarters · filed 2024-11-27 | $1.22M 10-K · filed 2024-11-27 |
| 2022-06-30 | $238.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-08 | $366.00K derived: sum of 2 quarters · filed 2023-08-08 | $412.00K 10-Q · filed 2023-08-08 | $533.00K derived: sum of 4 quarters · filed 2023-11-22 |
| 2022-03-31 | $128.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-09 | $174.00K 10-Q · filed 2023-05-09 | $295.00K derived: sum of 3 quarters · filed 2023-11-22 | $294.00K derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-12-31 | $46.00K 10-Q · filed 2023-02-08 | $167.00K derived: sum of 2 quarters · filed 2023-11-22 | $166.00K derived: sum of 3 quarters · filed 2023-11-22 | $121.00K derived: sum of 4 quarters · filed 2023-11-22 |
| 2021-09-30 | $121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-11-22 | $120.00K derived: sum of 2 quarters · filed 2023-11-22 | $75.00K derived: sum of 3 quarters · filed 2023-11-22 | $137.00K 10-K · filed 2023-11-22 |
| 2021-06-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-08 | -$46.00K derived: sum of 2 quarters · filed 2022-08-08 | $16.00K 10-Q · filed 2022-08-08 | -$95.00K derived: sum of 4 quarters · filed 2022-11-23 |
| 2021-03-31 | -$45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-09 | $17.00K 10-Q · filed 2022-05-09 | -$94.00K derived: sum of 3 quarters · filed 2022-11-23 | $96.00K derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-12-31 | $62.00K 10-Q · filed 2022-02-10 | -$49.00K derived: sum of 2 quarters · filed 2022-11-23 | $141.00K derived: sum of 3 quarters · filed 2022-11-23 | $34.00K derived: sum of 4 quarters · filed 2022-11-23 |
| 2020-09-30 | -$111.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-11-23 | $79.00K derived: sum of 2 quarters · filed 2022-11-23 | -$28.00K derived: sum of 3 quarters · filed 2022-11-23 | $188.00K 10-K · filed 2022-11-23 |
| 2020-06-30 | $190.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-09 | $83.00K derived: sum of 2 quarters · filed 2021-08-09 | $299.00K 10-Q · filed 2021-08-09 | $461.00K derived: sum of 4 quarters · filed 2021-11-24 |
| 2020-03-31 | -$107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-10 | $109.00K 10-Q · filed 2021-05-10 | $271.00K derived: sum of 3 quarters · filed 2021-11-24 | -$1.17M derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-12-31 | $216.00K 10-Q · filed 2021-02-09 | $378.00K derived: sum of 2 quarters · filed 2021-11-24 | -$1.06M derived: sum of 3 quarters · filed 2021-11-24 | -$768.00K derived: sum of 4 quarters · filed 2021-11-24 |
| 2019-09-30 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-11-24 | -$1.28M derived: sum of 2 quarters · filed 2021-11-24 | -$984.00K derived: sum of 3 quarters · filed 2021-11-24 | $320.00K 10-K · filed 2021-11-24 |
| 2019-06-30 | -$1.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-10 | -$1.15M derived: sum of 2 quarters · filed 2020-08-10 | $158.00K 10-Q · filed 2020-08-10 | $201.00K derived: sum of 4 quarters · filed 2020-11-25 |
| 2019-03-31 | $294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-11 | $1.60M 10-Q · filed 2020-05-11 | $1.64M derived: sum of 3 quarters · filed 2020-11-25 | $1.60M derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-12-31 | $1.30M 10-Q · filed 2020-02-10 | $1.35M derived: sum of 2 quarters · filed 2020-11-25 | $1.30M derived: sum of 3 quarters · filed 2020-11-25 | $1.30M derived: sum of 4 quarters · filed 2020-11-25 |
| 2018-09-30 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-25 | $0.00 derived: sum of 2 quarters · filed 2020-11-25 | $0.00 derived: sum of 3 quarters · filed 2020-11-25 | $111.00K 10-K · filed 2020-11-25 |
| 2018-06-30 | -$43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-09 | -$43.00K derived: sum of 2 quarters · filed 2019-08-09 | $68.00K 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-10 | $111.00K 10-Q · filed 2019-05-10 | ||
| 2017-12-31 | $111.00K 10-Q · filed 2019-02-08 | |||
| 2017-09-30 | $318.00K 10-K · filed 2019-11-27 | |||
| 2016-09-30 | $637.00K 10-K · filed 2018-11-29 | |||
| 2015-09-30 | $1.56M 10-K · filed 2017-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |